TA Associates is considering selling its majority stake in OmniActive Health Technologies Ltd., people familiar with the matter said.
The private equity firm is in talks with potential advisers about a possible sale and could seek a valuation of as much as $1 billion for the Indian company, the people said.
Deliberations are ongoing and may not lead to a transaction, the people said.
A representative for TA declined to comment. OmniActive didn’t immediately respond to a request for comment.
TA invested in OmniActive in 2021. OmniActive’s products include dietary supplements and beverages, TA’s website shows. Founded in 2005, OmniActive is headquartered in Mumbai and it has R&D and production facilities in India.

)